Wonderlab Bio
The World's First Fully Matched Allogeneic iPSC Cell Bank
Wonderlab Bio is a Boston-based regenerative medicine company operating the world's first fully characterized, HLA-matched induced pluripotent stem cell (iPSC) bank. Our platform features 65+ HLA-homozygous super donors covering more than 90% of the US population, enabling off-the-shelf cell therapies without immune rejection.
Therapeutic Programs
- G3N-004: Injectable cartilage repair for knee osteoarthritis (IND-track)
- G3N-008: Gene therapy for Long QT Syndrome (preclinical)
- G3N-012 BIOGAMI: Neurodegenerative disease targeting protein aggregation
Platform Highlights
- 85,000+ fully consented human donor samples
- 65+ HLA-homozygous super donors identified
- 90%+ US population coverage through HLA matching
- 23 patents spanning cell bank, manufacturing, and therapeutics
- $57M+ total platform investment
- 100% iPSC reprogramming success rate
- GMP-compatible, xeno-free manufacturing protocols
Contact
Wonderlab Bio, 27 Drydock Ave 2nd Floor, Boston, MA 02210
Email: info@wonderlab.bio